Literature DB >> 30207636

Otolaryngological features in a cohort of patients affected with 22q11.2 deletion syndrome: A monocentric survey.

Fiorentino Grasso1, Emilia Cirillo1, Giuseppe Quaremba2, Vincenzo Graziano2, Vera Gallo1, Letizia Cruoglio3, Carmine Botta4, Claudio Pignata1, Sergio Motta3.   

Abstract

Otorhinolaryngologic manifestations are common in 22q11.2 deletion syndrome (22q11.2DS), but poorly described. This study aimed to better define the ear-nose-throat (ENT) phenotype of 22q11.2DS patients, in the attempt to best detect subjects requiring subspecialist intervention. We enrolled 25 patients affected with 22q11.2DS. Anatomic and functional ENT findings were investigated using clinical, laboratory, and instrumental data. Immunophenotype and frequency of infections were evaluated. Univariate and multivariate analyses were performed. ENT anomalies were found in 88% of patients, and in 20% congenital palate defects required surgery. Adenoid or palatine tonsil hypertrophy was noted in 80% and 48%. Forty-eight percent of subjects had rhinolalia/phonia, severe in half of these. We also found nasal regurgitation or laryngeal penetration/aspiration in 20% and 16%, respectively. Instrumental exams revealed a mild conductive hearing loss in 32% (bilateral in most cases), tympanometric anomalies in 28%, and swallowing abnormalities in 16%. Statistical univariate analysis showed a direct association between rhinolalia/phonia and episodes of laryngeal aspiration (p = .016) and between tympanometric anomalies and increased adenoid volume (p = .044). No association between episodes of food aspiration and palatal anomalies was found. Moreover, no statistically significant association was observed between the number of airway infections and the ENT findings. This study contributes to better define the ENT phenotype in patients with 22q11.2DS, helpful to prevent potential complications. Furthermore, the identification of a subcategory of patients may allow the early adoption of specific speech therapy programs to improve the clinical outcome of 22q11.2DS patients.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  22q11.2 deletion syndrome; DiGeorge syndrome; ENT phenotype

Mesh:

Year:  2018        PMID: 30207636     DOI: 10.1002/ajmg.a.40518

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  2 in total

1.  Variations in maternal vitamin A intake modifies phenotypes in a mouse model of 22q11.2 deletion syndrome.

Authors:  Gelila Yitsege; Bethany A Stokes; Julia A Sabatino; Kelsey F Sugrue; Gabor Banyai; Elizabeth M Paronett; Beverly A Karpinski; Thomas M Maynard; Anthony-S LaMantia; Irene E Zohn
Journal:  Birth Defects Res       Date:  2020-05-20       Impact factor: 2.344

2.  Persistent Feeding and Swallowing Deficits in a Mouse Model of 22q11.2 Deletion Syndrome.

Authors:  Lauren Welby; Hailey Caudill; Gelila Yitsege; Ali Hamad; Filiz Bunyak; Irene E Zohn; Thomas Maynard; Anthony-Samuel LaMantia; David Mendelowitz; Teresa E Lever
Journal:  Front Neurol       Date:  2020-01-31       Impact factor: 4.003

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.